Honors English - Final Exam 2024 GCS 43個詞語 Austin_Flory9 預覽 vocabe week 4 10個詞語 anthonyfrias3 預覽 Weather 5個詞語 Lil_Jellybean123 預覽 Lit unit 5 11個詞語 ldavis287 預覽 Vocabulary for Places Around Town 26個詞語 Agastya_Vadde 預覽 Study questions 3 11個詞語 Kelsey_Cohen43 預覽...
For mirvetuximab soravtansine-gynx, total plasma clearance (mean [CV%]) of was 19 mL/hour (52%) and the mean terminal phase half-life after the first dose was 4.8 days leading to a steady state at approximately 24 days. For the unconjugated DM4, the total plasma clearance (mean [...
, Nov. 18, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with ...